(Q37725843)

22 August 2017

1 reference

title

A psychoneuroimmunological review on cytokines involved in antidepressant treatment response (English)

1 reference

22 August 2017

Debbie G A Janssen

1

1 reference

22 August 2017

Riccardo N Caniato

series ordinal

2

1 reference

22 August 2017

Joris C Verster

series ordinal

3

1 reference

22 August 2017

Bernhard T Baune

series ordinal

4

1 reference

22 August 2017

publication date

1 April 2010

1 reference

22 August 2017

published in

Human Psychopharmacology

1 reference

22 August 2017

volume

25

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

201-215

1 reference

Amitriptyline attenuates the febrile response to a pyrogen in rabbits

22 August 2017

cites work

1 reference

Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy

21 January 2018

1 reference

Lifetime risk of depression: restricted to a minority or waiting for most?

21 January 2018

1 reference

7 January 2021

Interleukin-1 beta production in dysthymia before and after pharmacotherapy

1 reference

7 January 2021

IL-6 levels decrease with SSRI treatment in patients with major depression.

1 reference

7 January 2021

A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice

1 reference

7 January 2021

Cytokines and depression: the need for a new paradigm

1 reference

7 January 2021

Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state.

1 reference

7 January 2021

Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat.

1 reference

7 January 2021

Effects of antidepressants on cytokine production and actions.

1 reference

7 January 2021

Gender, race/ethnicity, personality, and interleukin-6 in urban primary care patients

1 reference

7 January 2021

Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: effect of chronic desipramine treatment

1 reference

7 January 2021

Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment.

1 reference

7 January 2021

From inflammation to sickness and depression: when the immune system subjugates the brain

1 reference

7 January 2021

Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade

1 reference

7 January 2021

Aging is associated with greater nuclear NF kappa B, reduced I kappa B alpha, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans

1 reference

7 January 2021

Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder

1 reference

7 January 2021

Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression.

1 reference

7 January 2021

Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission

1 reference

7 January 2021

Differential expression of cytokines in subcutaneous and marrow fat of aging C57BL/6J mice

1 reference

7 January 2021

Depression and immunity: inflammation and depressive symptoms in multiple sclerosis

1 reference

7 January 2021

Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature

1 reference

7 January 2021

Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression

1 reference

7 January 2021

IFNgamma signaling-does it mean JAK-STAT?

1 reference

7 January 2021

Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide.

1 reference

7 January 2021

Depression and immunity: a meta-analytic review

1 reference

7 January 2021

Are cytokines associated with neuropsychiatric syndromes in humans?

1 reference

7 January 2021

Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis

1 reference

7 January 2021

Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine

1 reference

7 January 2021

The immune system in aging: roles of cytokines, T cells and NK cells

1 reference

7 January 2021

Depressive disorders and immunity: 20 years of progress and discovery

1 reference

7 January 2021

Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan

1 reference

7 January 2021

Anti- and pro-inflammatory considerations in antidepressant use during medical illness: bupropion lowers and mirtazapine increases circulating tumor necrosis factor-alpha levels

1 reference

7 January 2021

Effects of antidepressants on the production of cytokines

1 reference

7 January 2021

Sickness behavior as a new target for drug development

1 reference

7 January 2021

The plasma levels of interleukin-12 in schizophrenia, major depression and bipolar mania: effects of psychotropic drugs

1 reference

7 January 2021

IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress

1 reference

7 January 2021

Immune dysregulation in major depression: a critical review of existing evidence

1 reference

7 January 2021

Cytokines and the brain: implications for clinical psychiatry

1 reference

7 January 2021

Stimulatory effect of antidepressants on the production of IL-6.

1 reference

7 January 2021

Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10.

1 reference

7 January 2021

Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.

1 reference

7 January 2021

Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6.

1 reference

7 January 2021

Unaltered monocyte function in patients with major depression before and after three months of antidepressive therapy

1 reference

7 January 2021

Cytokine production and treatment response in major depressive disorder

1 reference

7 January 2021

The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder

1 reference

7 January 2021

The in vitro immunosuppressive effects of moclobemide in healthy volunteers

1 reference

7 January 2021

The association between C-reactive protein levels and depression: Results from the northern Finland 1966 birth cohort study.

1 reference

7 January 2021

The immunoregulatory effects of antidepressants

1 reference

7 January 2021

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

1 reference

7 January 2021

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

1 reference

7 January 2021

Negative Immunoregulatory Effects of Antidepressants Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion

1 reference

7 January 2021

The cellular neurobiology of depression

1 reference

7 January 2021

Cytokine profiles in women with different subtypes of major depressive disorder.

1 reference

7 January 2021

Evidence for a cytokine model of cognitive function

1 reference

7 January 2021

Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline

1 reference

7 January 2021

Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers.

1 reference

7 January 2021

Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis

1 reference

7 January 2021

Inflammatory markers and sleep disturbance in major depression

1 reference

7 January 2021

Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis

1 reference

7 January 2021

Plasma levels of adiponectin and tumor necrosis factor-alpha in patients with remitted major depression receiving long-term maintenance antidepressant therapy

1 reference

7 January 2021

Antidepressant drugs and cytokines in mood disorders

1 reference

7 January 2021

Cytokines: abnormalities in major depression and implications for pharmacological treatment.

1 reference

7 January 2021

Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy

1 reference

7 January 2021

Cytokine signaling in 2002: new surprises in the Jak/Stat pathway

1 reference

7 January 2021

Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.

1 reference

7 January 2021

Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression

1 reference

7 January 2021

Genetic and environmental influences on pro-inflammatory monocytes in bipolar disorder: a twin study

1 reference

7 January 2021

Pro-inflammatory biomakers in depression: treatment with venlafaxine

1 reference

7 January 2021

Low levels of circulating inflammatory cytokines--do they affect human brain functions?

1 reference

7 January 2021

Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression

1 reference

7 January 2021

Cytokines sing the blues: inflammation and the pathogenesis of depression

1 reference

7 January 2021

More on the depressive effects of interferon alfa.

1 reference

7 January 2021

Different immune patterns in melancholic and non-melancholic major depression

1 reference

7 January 2021

Inflammatory markers in major depression and melancholia

1 reference

7 January 2021

Lymphocyte subsets and lymphokine production in patients with melancholic versus nonmelancholic depression.

1 reference

7 January 2021

Monocytic parameters in patients with dysthymia versus major depression.

1 reference

7 January 2021

Depression and immunity: clinical factors and therapeutic course

1 reference

7 January 2021

Cytokine production and serum proteins in depression

1 reference

7 January 2021

Increased CD56+ natural killer cells and related cytokines in major depression

1 reference

7 January 2021

Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat

1 reference

7 January 2021

Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine

1 reference

7 January 2021

The macrophage theory of depression

1 reference

7 January 2021

The effect of thymectomy and IL-1 on memory: implications for the relationship between immunity and depression

1 reference

7 January 2021

Neuroendocrine and inflammatory factors associated with positive affect in healthy men and women: the Whitehall II study

1 reference

7 January 2021

The catecholamine cytokine balance: interaction between the brain and the immune system

1 reference

7 January 2021

The association between burnout, depression, anxiety, and inflammation biomarkers: C-reactive protein and fibrinogen in men and women.

1 reference

7 January 2021

Cytokines and serotonin transporter in patients with major depression.

1 reference

7 January 2021

Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder

1 reference

7 January 2021

Global burden of depressive disorders in the year 2000

1 reference

7 January 2021

Neuroscience. Depression drugs' powers may rest on new neurons

1 reference

7 January 2021

Cytokine production in major depressed patients before and after clomipramine treatment.

1 reference

7 January 2021

The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans

1 reference

7 January 2021

Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells

1 reference

7 January 2021

Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures

1 reference

7 January 2021

The Janus kinase family of protein tyrosine kinases and their role in signaling

1 reference

7 January 2021

Endotoxin produces a depressive-like episode in rats.

1 reference

7 January 2021

The role of brain cytokines in mediating the behavioral and neuroendocrine effects of intracerebral mycoplasma fermentans.

1 reference

7 January 2021

Association Study of the Interleukin-1beta (C-511T) Genetic Polymorphism with Major Depressive Disorder, Associated Symptomatology, and Antidepressant Response

1 reference

7 January 2021

The relationship of depression and stressors to immunological assays: a meta-analytic review

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.1103

1 reference

22 August 2017

1 reference